Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Rentokil
RTO
|
+$510M |
| 2 |
Apellis Pharmaceuticals
APLS
|
+$205M |
| 3 |
TFI International
TFII
|
+$146M |
| 4 |
Ambev
ABEV
|
+$133M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$132M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$8.38B |
| 2 |
Apple
AAPL
|
+$5.18B |
| 3 |
Mastercard
MA
|
+$3.67B |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$3.38B |
| 5 |
Amazon
AMZN
|
+$3.16B |
Sector Composition
| 1 | Technology | 28.11% |
| 2 | Healthcare | 21.42% |
| 3 | Financials | 11.42% |
| 4 | Industrials | 10.68% |
| 5 | Consumer Discretionary | 10.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2326
Enviri
NVRI
$938M
| $101K | ﹤0.01% |
16,029
-16,027
| -50% | -$101K |
|
2327
Esperion Therapeutics
ESPR
$506M
| $100K | ﹤0.01% |
+16,098
| New | +$100K |
|
2328
Opendoor
OPEN
$4.45B
| $100K | ﹤0.01% |
85,933
-85,949
| -50% | -$100K |
|
2329
Douglas Elliman
DOUG
$253M
| $99.8K | ﹤0.01% |
25,740
-31,523
| -55% | -$122K |
|
|
ACCD
2330
DELISTED
Accolade, Inc. Common Stock
ACCD
| $99.8K | ﹤0.01% |
+12,802
| New | +$99.8K |
|
2331
Allogene Therapeutics
ALLO
$253M
| $99.5K | ﹤0.01% |
15,837
-15,839
| -50% | -$99.6K |
|
2332
SiriusPoint
SPNT
$2.21B
| $98.3K | ﹤0.01% |
16,650
-16,650
| -50% | -$98.3K |
|
2333
TETRA Technologies
TTI
$633M
| $98.3K | ﹤0.01% |
+28,436
| New | +$98.3K |
|
2334
Smith & Wesson
SWBI
$392M
| $98K | ﹤0.01% |
11,301
-11,301
| -50% | -$98K |
|
2335
Alector
ALEC
$279M
| $97.3K | ﹤0.01% |
10,560
-10,560
| -50% | -$97.3K |
|
2336
Hims & Hers Health
HIMS
$11.2B
| $97.1K | ﹤0.01% |
15,165
-15,169
| -50% | -$97.2K |
|
2337
Lightwave Logic
LWLG
$399M
| $97K | ﹤0.01% |
22,541
-22,545
| -50% | -$97.1K |
|
2338
Community Health Systems
CYH
$415M
| $97K | ﹤0.01% |
22,485
-22,485
| -50% | -$97K |
|
2339
WideOpenWest
WOW
$441M
| $96.6K | ﹤0.01% |
10,595
-10,593
| -50% | -$96.6K |
|
|
EQRX
2340
DELISTED
EQRx, Inc. Common Stock
EQRX
| $95.1K | ﹤0.01% |
38,742
-38,744
| -50% | -$95.1K |
|
2341
Robinhood
HOOD
$104B
| $95K | ﹤0.01% |
11,671
-11,671
| -50% | -$95K |
|
2342
Coherus Oncology, Inc. Common Stock
CHRS
$159M
| $94.4K | ﹤0.01% |
11,926
-11,926
| -50% | -$94.4K |
|
|
TWOU
2343
DELISTED
2U, Inc.
TWOU
| $94.2K | ﹤0.01% |
501
-501
| -50% | -$94.2K |
|
2344
Radiant Logistics
RLGT
$304M
| $92.8K | ﹤0.01% |
+18,227
| New | +$92.8K |
|
|
ONL
2345
Orion Office REIT
ONL
$171M
| $92.7K | ﹤0.01% |
10,862
-10,862
| -50% | -$92.7K |
|
2346
Berry Corp
BRY
$248M
| $92.3K | ﹤0.01% |
11,562
-11,562
| -50% | -$92.3K |
|
2347
Ezcorp Inc
EZPW
$1.04B
| $90.8K | ﹤0.01% |
+11,124
| New | +$90.8K |
|
|
BRMK
2348
DELISTED
Broadmark Realty Capital Inc. Common Stock
BRMK
| $90.8K | ﹤0.01% |
25,530
-25,532
| -50% | -$90.8K |
|
2349
8x8 Inc
EGHT
$285M
| $89.7K | ﹤0.01% |
20,829
-20,829
| -50% | -$89.7K |
|
2350
ARKO Corp
ARKO
$569M
| $89.5K | ﹤0.01% |
10,345
-10,345
| -50% | -$89.5K |
|